Pfizer Inc.
PFE
PFE
Pfizer declared its 352nd straight quarterly dividend amid questions about its yield, backed by fundamentals including a market cap of $162.15B and annual revenue of $62.58B. The company currently shows an EPS TTM of 0.76, resulting in a PE ratio of 37.59. Meanwhile, Pfizer maintains a free cash flow yield of 6.78% to support its capital return profile.
Based on fool.comPfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe?
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put
6 Blue Chip Stocks Trading Well Below Their Highs
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.